Esperion Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
My name is Jason Zemansky. I'm one of the new SMID-cap analyst here at BofA. I'd like to welcome you to the final morning of our 2023 Healthcare Conference.
Very pleased this morning to be introducing Sheldon Koenig, President and CEO of Esperion Pharmaceuticals. His first, I believe, conference pending -- following the dispute.
Questions & Answers
So I think why don't we just dive in? And let me ask, maybe to start things off, a question on most investors' minds. I appreciate things are a little in flux and there are some restrictions here. But can you provide a little color on what's going on thus far with the lawsuit and maybe potential time lines for resolution?
Yes. Great. So first of all, Jason, thank you very much on behalf of all the employees of Esperion. We really appreciate the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |